Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 2
1967 1
1996 1
1999 1
2004 3
2005 2
2006 1
2008 5
2009 3
2010 7
2011 4
2012 4
2013 1
2014 3
2015 10
2016 4
2017 4
2018 4
2019 7
2020 6
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

71 results
Results by year
Filters applied: . Clear all
Page 1
Animal models for COVID-19.
Muñoz-Fontela C, Dowling WE, Funnell SGP, Gsell PS, Riveros-Balta AX, Albrecht RA, Andersen H, Baric RS, Carroll MW, Cavaleri M, Qin C, Crozier I, Dallmeier K, de Waal L, de Wit E, Delang L, Dohm E, Duprex WP, Falzarano D, Finch CL, Frieman MB, Graham BS, Gralinski LE, Guilfoyle K, Haagmans BL, Hamilton GA, Hartman AL, Herfst S, Kaptein SJF, Klimstra WB, Knezevic I, Krause PR, Kuhn JH, Le Grand R, Lewis MG, Liu WC, Maisonnasse P, McElroy AK, Munster V, Oreshkova N, Rasmussen AL, Rocha-Pereira J, Rockx B, Rodríguez E, Rogers TF, Salguero FJ, Schotsaert M, Stittelaar KJ, Thibaut HJ, Tseng CT, Vergara-Alert J, Beer M, Brasel T, Chan JFW, García-Sastre A, Neyts J, Perlman S, Reed DS, Richt JA, Roy CJ, Segalés J, Vasan SS, Henao-Restrepo AM, Barouch DH. Muñoz-Fontela C, et al. Among authors: cavaleri m. Nature. 2020 Oct;586(7830):509-515. doi: 10.1038/s41586-020-2787-6. Epub 2020 Sep 23. Nature. 2020. PMID: 32967005 Review.
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.
Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, Ouellette M, Outterson K, Patel J, Cavaleri M, Cox EM, Houchens CR, Grayson ML, Hansen P, Singh N, Theuretzbacher U, Magrini N; WHO Pathogens Priority List Working Group. Tacconelli E, et al. Among authors: cavaleri m. Lancet Infect Dis. 2018 Mar;18(3):318-327. doi: 10.1016/S1473-3099(17)30753-3. Epub 2017 Dec 21. Lancet Infect Dis. 2018. PMID: 29276051
Bacteriophage therapy: a regulatory perspective.
Pelfrene E, Willebrand E, Cavaleiro Sanches A, Sebris Z, Cavaleri M. Pelfrene E, et al. Among authors: cavaleri m. J Antimicrob Chemother. 2016 Aug;71(8):2071-4. doi: 10.1093/jac/dkw083. Epub 2016 Apr 10. J Antimicrob Chemother. 2016. PMID: 27068400
Clinical Trials for COVID-19: Can we Better Use the Short Window of Opportunity?
Eichler HG, Cavaleri M, Enzmann H, Scotti F, Sepodes B, Sweeney F, Vamvakas S, Rasi G. Eichler HG, et al. Among authors: cavaleri m. Clin Pharmacol Ther. 2020 Oct;108(4):730-733. doi: 10.1002/cpt.1891. Epub 2020 Jun 12. Clin Pharmacol Ther. 2020. PMID: 32407539 Free PMC article. Review.
The global threat of antimicrobial resistance: science for intervention.
Roca I, Akova M, Baquero F, Carlet J, Cavaleri M, Coenen S, Cohen J, Findlay D, Gyssens I, Heuer OE, Kahlmeter G, Kruse H, Laxminarayan R, Liébana E, López-Cerero L, MacGowan A, Martins M, Rodríguez-Baño J, Rolain JM, Segovia C, Sigauque B, Tacconelli E, Wellington E, Vila J. Roca I, et al. Among authors: cavaleri m. New Microbes New Infect. 2015 Apr 16;6:22-9. doi: 10.1016/j.nmni.2015.02.007. eCollection 2015 Jul. New Microbes New Infect. 2015. PMID: 26029375 Free PMC article. Review.
Monoclonal antibodies as anti-infective products: a promising future?
Pelfrene E, Mura M, Cavaleiro Sanches A, Cavaleri M. Pelfrene E, et al. Among authors: cavaleri m. Clin Microbiol Infect. 2019 Jan;25(1):60-64. doi: 10.1016/j.cmi.2018.04.024. Epub 2018 Apr 30. Clin Microbiol Infect. 2019. PMID: 29715552 Free PMC article. Review.
71 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page